ES2171477T3 - Derivados de acidos fosfinicos, su preparacion asi como su utilizacion. - Google Patents

Derivados de acidos fosfinicos, su preparacion asi como su utilizacion.

Info

Publication number
ES2171477T3
ES2171477T3 ES95109926T ES95109926T ES2171477T3 ES 2171477 T3 ES2171477 T3 ES 2171477T3 ES 95109926 T ES95109926 T ES 95109926T ES 95109926 T ES95109926 T ES 95109926T ES 2171477 T3 ES2171477 T3 ES 2171477T3
Authority
ES
Spain
Prior art keywords
unsatd
alkyl
satd
alk
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95109926T
Other languages
English (en)
Inventor
Anuschirwan Dr Peyman
Wilhelm Dr Stahl
Karl-Heinz Dr Budt
Dieter Dr Ruppert
Henning Schussler
Konrad Wagner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis Deutschland GmbH
Original Assignee
Aventis Pharma Deutschland GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Deutschland GmbH filed Critical Aventis Pharma Deutschland GmbH
Application granted granted Critical
Publication of ES2171477T3 publication Critical patent/ES2171477T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6564—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
    • C07F9/6581—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and nitrogen atoms with or without oxygen or sulfur atoms, as ring hetero atoms
    • C07F9/6584—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and nitrogen atoms with or without oxygen or sulfur atoms, as ring hetero atoms having one phosphorus atom as ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

COMPUESTOS DE LA FORMULA I EN DONDE LOS SIMBOLOS O SUSTITUYENTES A, B, D, D*, E, E* TIENEN EL SIGNIFICADO CONOCIDO, INHIBEN LAS PROTEASAS ASPARTILO Y SON APROPIADOS PARA LA LUCHA CONTRA ENFERMEDADES DE VIRUS.
ES95109926T 1994-06-30 1995-06-26 Derivados de acidos fosfinicos, su preparacion asi como su utilizacion. Expired - Lifetime ES2171477T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4422911A DE4422911A1 (de) 1994-06-30 1994-06-30 Phosphinsäure-Derivate, deren Herstellung sowie deren Verwendung

Publications (1)

Publication Number Publication Date
ES2171477T3 true ES2171477T3 (es) 2002-09-16

Family

ID=6521903

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95109926T Expired - Lifetime ES2171477T3 (es) 1994-06-30 1995-06-26 Derivados de acidos fosfinicos, su preparacion asi como su utilizacion.

Country Status (10)

Country Link
US (1) US5707979A (es)
EP (1) EP0690066B1 (es)
JP (1) JP3718262B2 (es)
AT (1) ATE214395T1 (es)
AU (1) AU708253B2 (es)
CA (1) CA2152973C (es)
DE (2) DE4422911A1 (es)
DK (1) DK0690066T3 (es)
ES (1) ES2171477T3 (es)
PT (1) PT690066E (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6716452B1 (en) * 2000-08-22 2004-04-06 New River Pharmaceuticals Inc. Active agent delivery systems and methods for protecting and administering active agents
US6627660B1 (en) * 1999-11-16 2003-09-30 New River Pharmaceuticals Inc. Stabilized thyroxine compounds
US8394813B2 (en) 2000-11-14 2013-03-12 Shire Llc Active agent delivery systems and methods for protecting and administering active agents
US7169752B2 (en) * 2003-09-30 2007-01-30 New River Pharmaceuticals Inc. Compounds and compositions for prevention of overdose of oxycodone
US20060014697A1 (en) * 2001-08-22 2006-01-19 Travis Mickle Pharmaceutical compositions for prevention of overdose or abuse
US9406531B1 (en) 2014-03-28 2016-08-02 STATS ChipPAC Pte. Ltd. Integrated circuit packaging system with photoimagable dielectric-defined trace and method of manufacture thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL89900A0 (en) 1988-04-12 1989-12-15 Merck & Co Inc Hiv protease inhibitors useful for the treatment of aids and pharmaceutical compositions containing them
EP0538374A4 (en) * 1990-07-06 1993-05-19 Smith-Kline Beecham Corporation Aspartic protease inhibitors
DE69221309T2 (de) 1991-10-11 1997-12-11 The Du Pont Merck Pharmaceutical Co., Wilmington, Del. Cyclische harnstoffe und analoga verwendbar als retrovirale proteasehemmer
EP0708760A1 (en) * 1993-07-14 1996-05-01 Novartis AG Cyclic hydrazine compounds

Also Published As

Publication number Publication date
JP3718262B2 (ja) 2005-11-24
EP0690066A1 (de) 1996-01-03
DK0690066T3 (da) 2002-07-01
PT690066E (pt) 2002-08-30
CA2152973A1 (en) 1995-12-31
AU2332495A (en) 1996-01-18
EP0690066B1 (de) 2002-03-13
ATE214395T1 (de) 2002-03-15
AU708253B2 (en) 1999-07-29
DE59510103D1 (de) 2002-04-18
CA2152973C (en) 2006-07-18
JPH0812694A (ja) 1996-01-16
US5707979A (en) 1998-01-13
DE4422911A1 (de) 1996-01-04

Similar Documents

Publication Publication Date Title
ES452920A1 (es) Procedimiento para preparar eteres de fenoles.
CO4920223A1 (es) Derivados de 1,3,8-triaza-espiro[4,5]decan-4-ona 8- sustituidos
AR245447A1 (es) Procedimiento para preparar derivados de 2,4-diamino-5-(biciclo-sustituido)metilpirimidinas.
PT88992A (pt) Processo para a preparacao de compostos contendo fosforo uteis como inibidores de colagenase
ES8107240A1 (es) Procedimiento para la preparacion de blanqueadores cationi- cos
ES2171477T3 (es) Derivados de acidos fosfinicos, su preparacion asi como su utilizacion.
IL98340A0 (en) Morpholinourea derivatives,their preparation and their use as insect-and mite repellants
DE69204694D1 (de) Verwendung von Indolderivaten als Koppler zur Färbung von keratinischen Fasern.
HUP0104033A2 (hu) Benzoilpiridazin-származékok, a vegyületeket tartalmazó gyógyszerkészítmények, eljárás az előállításukra és alkalmazásuk
ES8706698A1 (es) Procedimiento para preparar derivados de cefalosporina.
SE7813274L (sv) Peptidderivat och forfarande for framstellning derav
ES466366A1 (es) Un procedimiento para preparar derivados de metasulfonamido-benzamida.
ES2012648A6 (es) Procedimiento para la preparacion de nuevos derivados de 1,4-benzoxazina y 1,4-benzotiazina.
EP0267733A3 (en) Cephalosporin compounds, process for their preparation and pharmaceutical compositions containing them
CY1107937T1 (el) Προφαρμακα σε συνδετες υποδοχεα nmda
ES2102870T3 (es) Benzopiranos y composiciones farmaceuticas que los contienen.
BR9502649A (pt) Composto oligomérico e processo para sua preparação composição uso dos ditos compostos e processo de estabilização de material organico
SE7909751L (sv) 4,1-bensoxazepiner och tia-analoger derav
ES2131549T3 (es) Derivados macrolidas de 16 eslabones y su procedimiento de preparacion.
HU9600517D0 (en) New tricyclic derivatives, their preparation, their use for the preparation of optically active or valemic colchicine and thiocolchine and analogues or derivatives and intermediates
MX25858A (es) 3-[1-tiazolidinilbutil-4-piperazinil]-1h-indazolesun procedimiento para su preparacion y su uso comomedicamentos.
BG102488A (en) Pesticidal compounds, compositions and methods for their preparation
ATE3111T1 (de) Verfahren zur herstellung von phenyl-propylmorpholin- und -piperidin-derivaten.
EP0407621A4 (en) Benzothiazole derivatives
JPS56100771A (en) Benzoxazole derivative

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 690066

Country of ref document: ES